Drug Discovery Technologies

Drug Discovery Technologies

Report Scope:

This report provides detailed information on the drug discovery technologies market. This report analyzes the market trends of drug discovery technologies with data from 2023, estimates from 2024, projections of compound annual growth rates (CAGRs) through 2029 (forecast period 2024-2029), and regional markets of drug discovery technologies. This report highlights drug discovery technologies’ current and future market potential and gives a detailed analysis of the competitive environment. The report covers regulatory scenarios, drivers, restraints, and opportunities. This report also covers market projections for 2029 and the market share for key market players.

The market scope in this report is segmented into technologies and applications. Based on technologies, this report covers high-throughput screening (HTS), bioanalytical instruments, cell-based assays and reagents, genomics, bioinformatics, proteomics, and others, such as combinatorial chemistry, metabolomics, nanotechnology, and system biology. These technologies are further classified into subcategories for this report. The market is segmented based on application to oncology, cardiovascular diseases, neurodegenerative diseases, immunological diseases, and others.

The market has been segmented into North America, Europe, Asia-Pacific, and other world regions. The regional segment covers a detailed analysis of major countries such as the U.S., Canada, Germany, the U.K., Italy, Spain, France, Japan, China, South Korea, Australia, and India. For market estimates, data is provided for 2023, with forecasts for 2024 and projections for 2029.

The report’s goals include:

Analyzing technologies and applications.

Analyzing global market size and segmentation.

Identifying market constraints and drivers.

Providing detailed market forecasts through 2029.

Assessing market shares, competitiveness, and industry structure.

Identifying potential long-term impacts on the drug discovery technologies market.

Report Includes:

104 data tables and 34 additional tables

An analysis of the current and future global markets for drug discovery technologies

Analyses of global market trends, with market revenue data (sales figures) for 2021-2023, estimates for 2024, and projected CAGRs through 2029

Estimates of the market size and revenue forecasts for the global market for drug discovery technologies, with market share analysis by therapeutics, application, end user and region

Discussion of bioinformatics as a platform for drug discovery

A comparison between proteomics and genomics drug discovery technology

Comparative assessment of pharmacokinetics and pharmacodynamics, and classification of the techniques used in drug discovery

Discussions of the market dynamics, opportunities and challenges, as well as emerging technologies

Overview of the sustainability trends and ESG developments in the industry, with emphasis on the ESG practices of leading companies, their ESG rankings, and consumer attitudes

Competitive intelligence, including companies’ market shares, recent M&A activity and venture funding

Profiles of the leading companies, including Thermo Fisher Scientific Inc., Danaher Corp., Agilent Technologies Inc., Illumina, and Charles River Laboratories.

Companies Mentioned

Agilent Technologies Inc.
Bio-rad Laboratories Inc.
Bruker
Charles River Laboratories
Danaher Corp.
Illumina Inc.
Promega Corp.
Qiagen
Revvity
Thermo Fisher Scientific Inc.